A National Registry on Chinese Patients With Cystic Fibrosis

Peking Union Medical College Hospital200 enrolled

Overview

Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Pulmonary Function

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: Fulfilled WHO clinical diagnostic criteria for CF; Was in a stable phase with no respiratory infections for nearly 4 weeks; Subjects (or their guardians) signed informed consent. Exclusion Criteria: Patients with other bronchiectasis who did not meet the inclusion criteria; Those with severe cardiac or renal disease

Locations (1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Change in spirometry (FEV1 and FVC) of lymphangioleiomyomatosis patients.

Spirometry will be evaluated at baseline and through study completion, an average of 3 years.

Time frame: 10 years

Central Contacts

Xinlun Tian, M.D.

CONTACT

86-10-69155039 tianxl@pumch.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.